Genotype Triad for

HOTAIR LINC-ROR MALAT1 SLE long non-coding RNAs lupus nephritis single nucleotide polymorphism

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
11 May 2022
Historique:
received: 16 04 2022
revised: 04 05 2022
accepted: 06 05 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 29 5 2022
Statut: epublish

Résumé

Accumulating evidence supports the implication of long non-coding RNAs (lncRNAs) in autoimmune diseases, including systemic lupus erythematosus (SLE). LncRNA variants could impact the development and/or outcome of the disease with variable diagnostic/prognostic utility in the clinic. We aimed to explore the contribution of HOTAIR (rs10783618), LINC-ROR (rs1942347), and MALAT1 (rs3200401) variants to SLE susceptibility and/or severity in 163 SLE patients and age-/sex-matched controls using real-time TaqMan allelic discrimination PCR. HOTAIR rs10783618*C/C was associated with a 77% increased risk of SLE (OR = 1.77, 95%CI = 1.09−2.87, p = 0.020) under the recessive model. Similarly, MALAT1 rs3200401*T/T carriers were three times more likely to develop SLE (OR = 2.89, 95%CI = 1.42−5.90) under the recessive model. While the rs3200401*T/C genotype was associated with a 49−57% decreased risk of SLE under codominant (OR = 0.51, 95%CI = 0.31−0.82, p < 0.001) and over-dominant (OR = 0.43, 95%CI = 0.27−0.68, p < 0.001) models. LINC-ROR rs1942347*A/A patients were more likely to have a positive family history of SLE. At the same time, HOTAIR rs10783618*C/C was associated with a higher frequency of arthritis (p = 0.001) and the presence of oral ulcers (p = 0.002), while patients carrying rs10783618*T/T genotype were more likely to develop hair loss (p < 0.001), weight loss (p = 0.001), and neurological symptoms (p = 0.003). In conclusion, the studied lncRNAs, HOTAIR, and MALAT1 gene polymorphisms confer susceptibility for SLE, providing a potential theoretical basis for their clinical translation in SLE disease.

Identifiants

pubmed: 35626352
pii: diagnostics12051197
doi: 10.3390/diagnostics12051197
pmc: PMC9139987
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

IUBMB Life. 2019 Sep;71(9):1367-1381
pubmed: 31188529
Biomed Res Int. 2013;2013:251098
pubmed: 23862139
Curr Opin Rheumatol. 2014 Sep;26(5):482-92
pubmed: 25010439
Biomolecules. 2020 Dec 06;10(12):
pubmed: 33291347
Arthritis Rheumatol. 2020 Jun;72(6):985-996
pubmed: 31930717
Biochem Soc Trans. 2012 Aug;40(4):902-6
pubmed: 22817756
Nephrology (Carlton). 2019 Apr;24(4):472-480
pubmed: 29717517
Yonsei Med J. 2019 Nov;60(11):1081-1092
pubmed: 31637891
Arthritis Rheumatol. 2019 Sep;71(9):1400-1412
pubmed: 31385462
Clin Rev Allergy Immunol. 2016 Jun;50(3):333-44
pubmed: 26969025
Bioinformatics. 2006 Aug 1;22(15):1928-9
pubmed: 16720584
Biomed Pharmacother. 2018 Oct;106:584-592
pubmed: 29990846
Anticancer Res. 2014 Nov;34(11):6669-76
pubmed: 25368273
Am J Cancer Res. 2015 Feb 15;5(3):907-27
pubmed: 26045977
Cell Cycle. 2021 Feb;20(3):332-344
pubmed: 33467979
J Autoimmun. 2016 Dec;75:96-104
pubmed: 27481557
Biomed Res Int. 2016;2016:8631061
pubmed: 27429984
PLoS One. 2016 Apr 04;11(4):e0152834
pubmed: 27043015
Mol Immunol. 2019 Aug;112:22-29
pubmed: 31075559
Cancers (Basel). 2020 Nov 15;12(11):
pubmed: 33203119
J Rheumatol. 2006 Aug;33(8):1563-9
pubmed: 16881113
Orphanet J Rare Dis. 2013 Jan 07;8:2
pubmed: 23289717
Nat Rev Rheumatol. 2020 Mar;16(3):126
pubmed: 32005955
Annu Rev Immunol. 2017 Apr 26;35:177-198
pubmed: 28125358
Semin Nephrol. 2010 Mar;30(2):164-76
pubmed: 20347645
J Cell Physiol. 2017 Dec;232(12):3422-3432
pubmed: 28067428
Arthritis Rheum. 1992 Jun;35(6):630-40
pubmed: 1599520
Biomolecules. 2020 Jun 22;10(6):
pubmed: 32580306
Oncotarget. 2017 Aug 24;8(44):77400-77406
pubmed: 29100395
Autoimmun Rev. 2019 Apr;18(4):382-392
pubmed: 30772495
J Biomed Mater Res A. 2019 Feb;107(2):468-475
pubmed: 30478988
Anticancer Res. 2012 Apr;32(4):1119-36
pubmed: 22493341
Cell Death Dis. 2018 Jun 15;9(7):711
pubmed: 29907764
Clin Exp Immunol. 2017 Mar;187(3):327-336
pubmed: 27880973
FASEB J. 2020 May;34(5):6070-6085
pubmed: 32246794
Wound Repair Regen. 2021 May;29(3):495-504
pubmed: 33721916
Arthritis Care Res (Hoboken). 2014 Apr;66(4):608-16
pubmed: 24106157
Cell Biosci. 2017 Apr 21;7:19
pubmed: 28439401
Braz J Med Biol Res. 2020 Apr 17;53(5):e9292
pubmed: 32321151
Curr Rheumatol Rep. 2019 Jan 23;21(1):3
pubmed: 30673885
Clin Exp Med. 2015 Feb;15(1):121-6
pubmed: 24722995
Front Med (Lausanne). 2018 Jul 03;5:193
pubmed: 30018955
J Clin Med. 2021 Oct 30;10(21):
pubmed: 34768615
Biochim Biophys Acta Rev Cancer. 2020 Jan;1873(1):188316
pubmed: 31639408
BMC Mol Cell Biol. 2020 Jul 10;21(1):53
pubmed: 32650720
Cytokine. 2021 Feb;138:155397
pubmed: 33341002
J Mol Neurosci. 2020 Oct;70(10):1533-1540
pubmed: 32578033
Cells. 2019 Sep 30;8(10):
pubmed: 31575058
Rheum Dis Clin North Am. 2014 Aug;40(3):401-12, vii
pubmed: 25034153
Diagnostics (Basel). 2021 Jul 26;11(8):
pubmed: 34441278
Melanoma Res. 2014 Aug;24(4):335-41
pubmed: 24892958
Lupus. 2021 Oct;30(12):1923-1930
pubmed: 34482739
Epigenetics. 2014 Jan;9(1):21-6
pubmed: 24335342
Int J Mol Sci. 2019 Nov 09;20(22):
pubmed: 31717552
Arthritis Res Ther. 2020 Dec 10;22(1):286
pubmed: 33303026
Tumour Biol. 2015 Apr;36(4):2845-54
pubmed: 25476857
Front Immunol. 2018 Dec 18;9:2967
pubmed: 30619325
Int Immunopharmacol. 2021 Sep;98:107903
pubmed: 34192661

Auteurs

Nesreen M Ismail (NM)

Department of Rheumatology and Rehabilitation, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.

Eman A Toraih (EA)

Division of Endocrine and Oncologic Surgery, Department of Surgery, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Genetics Unit, Department of Histology and Cell Biology, Suez Canal University, Ismailia 41522, Egypt.

Amany I Almars (AI)

Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.

Essam Al Ageeli (E)

Department of Clinical Biochemistry (Medical Genetics), Faculty of Medicine, Jazan University, Jazan 45142, Saudi Arabia.

Manal S Fawzy (MS)

Department of Biochemistry, Faculty of Medicine, Northern Border University, Arar 1321, Saudi Arabia.

Shymaa Ahmed Maher (SA)

Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
Center of Excellence in Molecular and Cellular Medicine (CEMCM), Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.

Classifications MeSH